GridAI Technologies (GRDX) EBIT (2015 - 2026)
GridAI Technologies' (GRDX) quarterly EBIT came in at -$13.1 million in Q2 2026, down 1951.57% on a YoY basis from $707871.7 in Q2 2025, and down 179.56% quarter-over-quarter from -$4.7 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) EBIT (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported EBIT for 12 consecutive years, with -$13.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT fell 1951.57% year-over-year to -$13.1 million; the trailing twelve-month figure through Jun 2026 stood at -$19.4 million (down 325.09% YoY), and the FY2025 full-year result was -$7.1 million, up 54.66% from the prior year.
- EBIT retreated to -$13.1 million in Q2 2026 per GRDX's latest filing, from -$4.7 million in the prior quarter.
- Across five years, EBIT topped out at $4.4 million in Q3 2022 and bottomed at -$13.1 million in Q2 2026.
- Historically, EBIT has averaged -$3.8 million across 5 years, with a median of -$3.4 million in 2023.
- The sharpest annual moves came in 2022 and 2026: EBIT jumped 114.44% in 2022, then plunged 1951.57% in 2026.
- Over 5 years, EBIT stood at -$2.3 million in 2022, then tumbled by 79.57% to -$4.1 million in 2023, then jumped by 70.6% to -$1.2 million in 2024, then tumbled by 289.56% to -$4.7 million in 2025, then plunged by 179.56% to -$13.1 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$13.1 million, -$4.7 million, and -$934787.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.12 Bn | 192.13 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 180.16 Bn | 176.98 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.01 Bn | 29.70 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -365.99 Mn |
| 10 | GridAI Technologies | 19.39 Mn | 19.39 Mn | -36,514.00 | -13.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.11 Mn |
| Dec 31, 2025 | -4.69 Mn |
| Sep 30, 2025 | -934,787.00 |
| Jun 30, 2025 | -638,864.00 |
| Mar 31, 2025 | -821,386.00 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -1.89 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -4.09 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.18 Mn |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.39 Mn |
| Jun 30, 2022 | -5.41 Mn |
| Mar 31, 2022 | -9.38 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.40 Mn |
| Jun 30, 2021 | -9.28 Mn |